The use of GLP-1R agonists was associated with fewer intra-articular injections of steroids and a lower cartilage loss velocity from the medial femoral joint, but the direct effects of GLP-1R agonist, apart from the weight loss-mediated pathway, did not reach statistical significance.
← all excerpts
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review.
1
—
—